Mesothelioma news | Breaking mesothelioma news | Mesothelioma

Memorial golf outing scheduled on May 18

...It invades the lining of the lungs, heart or stomach until it destroys vital organ.For decades, research to cure the disease was neglected, and those it afflicted were ignored.

Currently, available treatments usually have only a limited effect, and prognosis is very poor.

After diagnosis, the life span is usually only four to 24 months on average.Make checks payable to the Larry Lohr Memorial Golf Outing.

They can be sent to Lohr's daughter, Cindy H.

Jesso, 366 Mt.

Joy Road, Mount Pleasant, PA 15666.For more information about the golf outing, call Jesso at 724-547-5427.

Updated 04/14/2007 12:02:20 AM EDT ŠThe Herald Standard 2007 Submit your comment now Comment Title: Submit your comments on the article in the space below: Your Name: Your City & State: Your Email Address: (required) By submitting your comment, you acknowledge that you have read and accept the Terms and Conditions of this site.

Email to a friendPost a CommentPrinter-friendlyTopNewsSportsObituariesClassifiedsArchivesJob SearchMarketplaceSpecial Sectio...

Alfacell, Onconase Inhibits Tumor Growth Of Non-small Cell Lung ...

... "This research adds to the extensive published data that supports our continued development of Onconase for multiple cancer indications.

The Onconase franchise includes the gateway indication of malignant The Bloomfield, New Jersey-based company said Onconase is a first-in-class therapeutic product candidate based on Alfacell's proprietary ribonuclease technology.

A natural protein isolated from the leopard frog, Onconase has been shown to target cancer cells while sparing normal cells.

Onconase triggers apoptosis, the natural death of cells, via multiple molecular mechanisms of action.

ACEL is trading at $2.87, up $0.38 or 15.26% on a volume of 2.16 million shares.

Copyright(c) 2007 RealTimeTraders.com, Inc.

All Rights Reserved Related Articles Alfacell, Onconase Inhibits Tumor Growth Of Non-small Cell Lung Cancer, Breast Cancer Cells - Update Alfacell Corp.

Is Trading Higher In Pre-open Following News Alfacell Says Preclinical Data Show ONCONASE Inhibits Tumor Growth Of Non-Small Cell Lung Cancer, Breast Cancer Cells - Quick Facts *Alfacell Says Preclinical Data Show ONCONASE Inhibits Tumor Growth Of Non-Small Cell Lung Cancer, Breast Cancer Cells Alfacell Says Vivo Study R...

Alfacell sees positive Onconase results

...The stock has traded between 73 cents and $3.94 over the last 52 weeks.Copyright 2007 Associated Press.

All rights reserved.

This material may not be published, broadcast, rewritten, or redistributed.

Share on digg rawsugar You Might Like Amsterdam shares AFX at a glance outlook German shares AFX at a glance outlook Brussels shares AFX at a glance outlook Swiss shares AFX at a glance outlook Paris shares AFX at a glance outlook Comment on this Article Comment: Title: Name: Please Enter Here Search News Browse ABCmoney News Archive Look For Business Credit cards Finance Loans Money Mortgages Stock Quotes * SYMBOL LAST CHANGE DOW JONES 12711.44 +99.31 ( 0.79 %) NASDAQ 2516.17 +24.23 ( 0.97 %) FTSE 100 6516.20 +99.80 ( 1.54 %) SYMBOL ( 2007-04-16 ...

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | All news